TREA

97017726

Follow

Information

  • Trademark
  • 97017726
  • Serial Number
    97017726
  • Registration Number
    7032317
  • Filing Date
    September 08, 2021
    3 years ago
  • Registration Date
    April 18, 2023
    a year ago
  • Transaction Date
    April 18, 2023
    a year ago
  • Status Date
    April 18, 2023
    a year ago
  • Published for Opposition Date
    July 19, 2022
    2 years ago
  • Location Date
    March 12, 2023
    a year ago
  • First Use Anywhere Date
    March 23, 2022
    2 years ago
  • First Use In Commerce Date
    April 20, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LATTUCA, FRANK J
  • Attorney Docket Number
    210177HUAS-U
    Attorney Name
    Yue (Robert) Xu
    Law Office Assigned Location Code
    L90
  • Owners
Information
Mark Drawing Code
2000
Case File Statements
  • DM0000: The mark consists of four Chinese characters in horizontal arrangement.
  • GS0051: Anti-cancer preparations; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Human vaccine preparations; Antibiotics for human use; Dietary supplements for human consumption; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Radioactive substances for medical purposes; Gases for medical and dental use; Gases and gas mixtures for medical imaging use; Cartridges sold pre-filled with gases and gas mixtures for medical use; Disinfectants; Bacteriological culture mediums; Dietetic foods adapted for medical purposes; Surgical dressings; All containing in whole or significant part, gene therapy substances
  • TLIT00: The non-Latin characters in the mark transliterate to "Hua" "Sang" "Mei" "Jin" and this means "Splendid" "Mulberry" "Beauty" "Saliva" in English.
Case File Event Statements
  • 4/18/2023 - a year ago
    17 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/18/2023 - a year ago
    16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/14/2023 - a year ago
    15 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 3/12/2023 - a year ago
    14 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 3/10/2023 - a year ago
    13 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 2/22/2023 - a year ago
    12 - USE AMENDMENT FILED Type: IUAF
  • 3/10/2023 - a year ago
    11 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 2/22/2023 - a year ago
    10 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 9/13/2022 - 2 years ago
    9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/19/2022 - 2 years ago
    8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/19/2022 - 2 years ago
    7 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/29/2022 - 2 years ago
    6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/12/2022 - 2 years ago
    5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/12/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/19/2021 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/18/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/11/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP